# A Study of Famitinib in Patients With Advanced Colorectal Cancer

> **NCT01762293** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 154 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Cancer Metastatic
- Colorectal Cancer Recurrent

## Interventions

- **DRUG:** Famitinib
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01762293
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762293, "A Study of Famitinib in Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01762293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*